Skip to main content

Table 2 Baseline Characteristics of Enrolled Participants (N = 25)

From: Antihyperlipidemic effects of Pleurotus ostreatus (oyster mushrooms) in HIV-infected individuals taking antiretroviral therapy

Participant Characteristic n Mean %
Years of age   46.4  
Male gender 24   96
Race/ethnicity    
   Caucasian 17   68
   African American 4   16
   Latino 4   16
Years HIV-infected   13.7  
CD4 cell count   494/mm3  
HIV RNA < 75 copies/mL 19   76
Months on HAART   82.3  
Target dyslipidemia-inducing agents    
   lopinavir/ritonavir 15   60
   atazanavir/ritonavir 3   12
   tipranavir/ritonavir 1   4
   fosamprenavir/ritonavir 1   4
   efavirenz 5   20
Months on target agent   19.0  
History of opportunistic infection 13   52
Cardiac risk factors    
   Lipodystrophy 13   52
   hypertension 7   28
   family history of hypertension 9   36
   family history of hyperlipidemia 11   44
   tobacco smokers 8   32
   former smokers 7   28
   alcohol users 15   60
   former alcohol users 5   20
   illicit substance users 14   56
   former illicit substance users 7   28
Prior antihyperlipidemic use: 9   36
\